blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3664793

EP3664793 - MACROCYCLIC IMMUNOMODULATORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.05.2023
Database last updated on 16.11.2024
FormerThe patent has been granted
Status updated on  27.05.2022
FormerGrant of patent is intended
Status updated on  23.05.2022
FormerRequest for examination was made
Status updated on  06.05.2022
FormerGrant of patent is intended
Status updated on  09.01.2022
FormerRequest for examination was made
Status updated on  15.05.2020
FormerThe international publication has been made
Status updated on  16.02.2019
Most recent event   Tooltip15.11.2024Change - lapse in a contracting state
Updated state(s): BG		published on 18.12.2024 [2024/51]
Applicant(s)For all designated states
ChemoCentryx, Inc.
835 Industrial Road, Suite 600
San Carlos, CA 94070 / US
[2022/17]
Former [2020/25]For all designated states
ChemoCentryx, Inc.
850 Maude Avenue
Mountain View, California 94043 / US
Inventor(s)01 / MALATHONG, Viengkham
121988 San Luis Avenue 3
Mountain View, CA 94043 / US
02 / MCMAHON, Jeffrey
15 Alta Mar Way
San Francisco, CA 94121 / US
03 / MCMURTRIE, Darren, J.
886 Lakewood Drive
Sunnyvale, CA 94085 / US
04 / PUNNA, Sreenivas
938 Fontana Terrace
Sunnyvale, CA 94085 / US
05 / ROTH, Howard, S.
675 Tasman Drive
Apt. 2320
Sunnyvale, CA 94089 / US
06 / SINGH, Rajinder
1832 Hillman Avenue
Belmont, CA 94002 / US
07 / ZHANG, Penglie
1036 Jamaica Street
Foster City, CA 94404 / US
 [2020/25]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2022/26]
Former [2020/25]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date18844749.407.08.2018
[2020/25]
WO2018US45553
Priority number, dateUS201762542694P08.08.2017         Original published format: US 201762542694 P
[2020/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019032547
Date:14.02.2019
Language:EN
[2019/07]
Type: A1 Application with search report 
No.:EP3664793
Date:17.06.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 14.02.2019 takes the place of the publication of the European patent application.
[2020/25]
Type: B1 Patent specification 
No.:EP3664793
Date:29.06.2022
Language:EN
[2022/26]
Search report(s)International search report - published on:US14.02.2019
(Supplementary) European search report - dispatched on:EP04.03.2021
ClassificationIPC:C07D498/08, A61K31/195, A61K31/335, C07C15/24, C07D273/02, C07D471/08
[2021/14]
CPC:
C07D498/08 (EP,IL,KR,US); C07D273/02 (EP,IL); A61K31/439 (IL,KR);
A61K31/5395 (IL); A61K45/06 (KR); A61P29/00 (IL);
A61P31/00 (IL); A61P31/04 (EP,IL,KR,US); A61P31/10 (EP,IL,KR,US);
A61P31/12 (EP,IL,KR,US); A61P35/00 (EP,IL,KR,US); A61P37/02 (EP,IL,KR,US);
C07D471/08 (EP); C07D471/18 (IL) (-)
Former IPC [2020/25]A61K31/195, A61K31/335, C07C15/24
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/25]
Extension statesBA05.02.2020
ME05.02.2020
Validation statesKH05.02.2020
MA05.02.2020
MD05.02.2020
TN05.02.2020
TitleGerman:MAKROZYKLISCHE IMMUNOMODULATOREN[2020/25]
English:MACROCYCLIC IMMUNOMODULATORS[2020/25]
French:IMMUNOMODULATEURS MACROCYCLIQUES[2020/25]
Entry into regional phase05.02.2020National basic fee paid 
05.02.2020Search fee paid 
05.02.2020Designation fee(s) paid 
05.02.2020Examination fee paid 
Examination procedure05.02.2020Examination requested  [2020/25]
22.09.2021Amendment by applicant (claims and/or description)
10.01.2022Communication of intention to grant the patent
04.05.2022Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
04.05.2022Fee for grant paid
04.05.2022Fee for publishing/printing paid
04.05.2022Receipt of the translation of the claim(s)
Opposition(s)30.03.2023No opposition filed within time limit [2023/23]
Fees paidRenewal fee
13.08.2020Renewal fee patent year 03
13.08.2021Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.08.2018
AL29.06.2022
AT29.06.2022
BG29.06.2022
CY29.06.2022
CZ29.06.2022
DK29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
MK29.06.2022
MT29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SI29.06.2022
SK29.06.2022
SM29.06.2022
TR29.06.2022
IE07.08.2022
LU07.08.2022
BE31.08.2022
CH31.08.2022
LI31.08.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
[2024/51]
Former [2024/44]HU07.08.2018
AL29.06.2022
AT29.06.2022
CY29.06.2022
CZ29.06.2022
DK29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
MK29.06.2022
MT29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SI29.06.2022
SK29.06.2022
SM29.06.2022
TR29.06.2022
IE07.08.2022
LU07.08.2022
BE31.08.2022
CH31.08.2022
LI31.08.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2024/29]HU07.08.2018
AL29.06.2022
AT29.06.2022
CY29.06.2022
CZ29.06.2022
DK29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
MK29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SI29.06.2022
SK29.06.2022
SM29.06.2022
TR29.06.2022
IE07.08.2022
LU07.08.2022
BE31.08.2022
CH31.08.2022
LI31.08.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2024/27]HU07.08.2018
AL29.06.2022
AT29.06.2022
CY29.06.2022
CZ29.06.2022
DK29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
MK29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SI29.06.2022
SK29.06.2022
SM29.06.2022
IE07.08.2022
LU07.08.2022
BE31.08.2022
CH31.08.2022
LI31.08.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2024/24]HU07.08.2018
AL29.06.2022
AT29.06.2022
CY29.06.2022
CZ29.06.2022
DK29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SI29.06.2022
SK29.06.2022
SM29.06.2022
IE07.08.2022
LU07.08.2022
BE31.08.2022
CH31.08.2022
LI31.08.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2024/20]AL29.06.2022
AT29.06.2022
CY29.06.2022
CZ29.06.2022
DK29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SI29.06.2022
SK29.06.2022
SM29.06.2022
IE07.08.2022
LU07.08.2022
BE31.08.2022
CH31.08.2022
LI31.08.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2023/42]AL29.06.2022
AT29.06.2022
CZ29.06.2022
DK29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SI29.06.2022
SK29.06.2022
SM29.06.2022
IE07.08.2022
LU07.08.2022
BE31.08.2022
CH31.08.2022
LI31.08.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2023/37]AL29.06.2022
AT29.06.2022
CZ29.06.2022
DK29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SI29.06.2022
SK29.06.2022
SM29.06.2022
IE07.08.2022
LU07.08.2022
CH31.08.2022
LI31.08.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2023/33]AL29.06.2022
AT29.06.2022
CZ29.06.2022
DK29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SK29.06.2022
SM29.06.2022
IE07.08.2022
LU07.08.2022
CH31.08.2022
LI31.08.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2023/22]AL29.06.2022
AT29.06.2022
CZ29.06.2022
DK29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SK29.06.2022
SM29.06.2022
LU07.08.2022
CH31.08.2022
LI31.08.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2023/21]AL29.06.2022
AT29.06.2022
DK29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SK29.06.2022
SM29.06.2022
LU07.08.2022
CH31.08.2022
LI31.08.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2023/17]AL29.06.2022
AT29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SK29.06.2022
SM29.06.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2023/16]AT29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
MC29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SK29.06.2022
SM29.06.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2023/12]AT29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SK29.06.2022
SM29.06.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
IS29.10.2022
PT31.10.2022
Former [2023/11]AT29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
NL29.06.2022
PL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SK29.06.2022
SM29.06.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
PT31.10.2022
Former [2023/09]AT29.06.2022
EE29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
NL29.06.2022
RO29.06.2022
RS29.06.2022
SE29.06.2022
SK29.06.2022
SM29.06.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
PT31.10.2022
Former [2023/07]AT29.06.2022
FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
NL29.06.2022
RS29.06.2022
SE29.06.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
Former [2023/02]FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
NL29.06.2022
RS29.06.2022
SE29.06.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
Former [2022/50]FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
RS29.06.2022
SE29.06.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
Former [2022/49]FI29.06.2022
HR29.06.2022
LT29.06.2022
LV29.06.2022
SE29.06.2022
BG29.09.2022
NO29.09.2022
GR30.09.2022
Former [2022/47]FI29.06.2022
LT29.06.2022
SE29.06.2022
NO29.09.2022
Cited inInternational search[A]US5604294  (LULY JAY R [US], et al);
 [A]US2014294898  (MILLER MICHAEL MATTHEW [US], et al);
 [A]WO2015034820  (BRISTOL MYERS SQUIBB CO [US]);
 [A]WO2017066227  (BRISTOL MYERS SQUIBB CO [US]);
 [A]WO2017070089  (INCYTE CORP [US])
by applicantUS4166452
 US4256108
 US4265874
 WO2015034820
 WO2015033299
 WO2015033301
 WO2015160641
 WO2016142886
 WO2016142894
 WO2017066227
 US2017107216
 WO2017070089
 US2017145025
 WO2017106634
 US2017174679
 WO2017112730
 WO2017192961
 WO2017205464
 WO2017222976
 WO2018000905
 WO2018013789
 WO2018044963
 WO2018044783
 WO2018051254
 WO2018051255
 WO2018118848
 WO2018119221
 WO2018119224
 WO2018119236
 WO2018119263
 WO2018119266
 WO2018119286
 US20020012680
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.